Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors
A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.
| Open | 912.56 | Prev Close | 917.34 |
| High | 918.51 | Low | 910.01 |
| Volume | 2,059,062 | Volume (Avg) | 2,255 |
| 52 Week High | 1,075.34 | 52 Week Low | 864.06 |
| Market Cap | 406.6B | PE Ratio | 50.35 |
General
| Name | Costco Wholesale Corp |
| Ticker | COST |
| Exchange | NASDAQ |
| Sector | Consumer Defensive |
| Industry | Discount Stores |
| Currency | USD |
| Country | USA |
| Fiscal Year End | August |
| Full Time Employees | 333,000 |
About Costco Wholesale Corp
Costco Wholesale Corporation, together with its subsidiaries, engages in the operation of membership warehouses in the United States, Puerto Rico, Canada, Mexico, Japan, the United Kingdom, Korea, Australia, Taiwan, China, Spain, France, Iceland, New Zealand, and Sweden. The company offers branded and private-label products in a range of merchandise categories. It offers merchandise, such as sundries, dry groceries, candies, coolers, freezers, deli, liquor, and tobacco; appliances, electronics, health and beauty aids, hardware, lawn and garden, sporting goods, tires, toys and seasonal products, office supplies, automotive care products, postages, tickets, apparel, small appliances, furniture, domestics, housewares, special order kiosks, and jewelry; and meat, produce, service deli, and bakery products. The company also operates gasoline, pharmacies, optical, food courts, hearing-aid centers, and tire installation centers; and offers business delivery, travel, grocery, and various other services online. It also operates e-commerce websites. The company was formerly known as Costco Companies, Inc. and changed its name to Costco Wholesale Corporation in August 1999. Costco Wholesale Corporation was founded in 1976 and is based in Issaquah, Washington.
Highlights
| Analyst Target | 1,077.20 |
| Market Cap | 406,566,500,000 |
| PE Ratio | 50.35 |
| PEG Ratio | 4.87 |
| EBITDA | 12,808,999,936 |
Valuation
| Trailing PE | 50.24 |
| Forward PE | 45.25 |
| Price/Sales (Trailing 12 Mt.) | 1.48 |
| Price/Book (Most Recent Quarter) | 13.92 |
Technicals
| Beta | 0.99 |
| 52 Week High | 1,075.34 |
| 52 Week Low | 864.06 |
| 50 Day Average | -3.88% |
| 200 Day Average | -5.87% |
Dividend
Costco Wholesale Corp pays out a dividend of $5.42 per share, with a dividend yield of 0.59%.
COST's last dividend payment was made to shareholders on August 15, 2025.
They pay out 27.02% of their earnings out as a dividend.
Recent Dividends
| Aug 15, 2025 | $1.30 |
| May 16, 2025 | $1.30 |
| Feb 21, 2025 | $1.16 |
| Nov 15, 2024 | $1.16 |
| Aug 9, 2024 | $1.16 |
| May 10, 2024 | $1.16 |
| Feb 16, 2024 | $1.02 |
| Jan 14, 2024 | $15 |
| Nov 17, 2023 | $1.02 |
Tesla Engineer Slams Elon Musk In Farewell Post, Questions CEO's Leadership: 'Elon Has Dealt Huge Damage...'
Tesla engineer slams Elon Musk's leadership, accusing him of lying and manipulating public discourse, as well as his political activities.
FBI Director Kash Patel Bought 2 Stocks In 2025 — One's Already A Meme Favorite
FBI Director Kash Patel was asked about two stocks he bought earlier this year by a member of Congress on Wednesday and gave a surprising answer. The transactions come as members of Congress are working on legislation to ban lawmakers and cabinet members from buying and selling stocks.
Why This Crypto Skeptic Had a Change of Heart - Ad
He used to make fun of crypto. Now... he says one $3 crypto could rise to $92 by next year.
Cathie Wood Dumps $5.2 Million Worth of This AI Stock, Here's What Ark Bought Instead
Ark Invest decided to sell shares of Tempus AI (TEM), despite positive news of FDA clearance for its diagnostic device. They also made other key trades.
IBM Stock Jumps 5% After Quantum Computing Breakthrough
Shares of International Business Machines Corporation (NASDAQ: IBM) are up Thursday after the company announced it reached a technological milestone in quantum computin
New Biotech Offering Targets $426B Rare Disease Market - Ad
The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.
America Has A New No. 1 Beer — And It's Got Bud Light DNA
When it comes to beer in the United States, there's a new bestselling brand.
3 Gold Mining Stocks Shine As Prices Hit Records
Gold mining stocks Anglogold Ashanti, Coeur Mining, and New Gold join the top 10% for quality as gold prices hit fresh highs.
Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad
This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.
Donald Trump Declares Harsh Media Coverage of Him 'No Longer Free Speech' But 'Illegal'
President Donald Trump has labeled negative media coverage of him as "illegal."
Bitcoin Struggles Around $112,000, But Here's Why The Bull Run Is Not Over Yet
Bitcoin's (CRYPTO: BTC) is languishing around $112,000, but a prominent trader remains adamant about a strong end to the year.
The "Mar-A-Lago Accord" Is Now Underway - Ad
The global order is in chaos. And according to 40-year market veteran Dr. David Eifrig, the biggest controlled demolition of the old monetary order in history could now be here, too. That means if you don't take action today, your wealth could decline by 40%... (Yes, even your cash savings.)
It's 'do or die' for electric vehicle maker Rivian as it breaks ground on a $5 billion plant
ATLANTA (AP) — It seems like a terrible time to build an electric vehicle plant in the United States, but Rivian Automotive leaders say they're confident as the company starts on a $5 billion facility in Georgia.
BlackRock Turns Popular Mutual Funds Into Global Equity ETFs
BlackRock turns two top mutual funds into active ETFs, giving investors global equity exposure and strategies to manage volatility.
Want To Know the No.1 Crypto and the No.1 Stock? - Ad
The #1 crypto is just $3. Crypto analysts say a cash injection could drive it as high as $100 in the next year. The #1 stock is equally exciting. It's less than $10 but made a HUGE deal recently to work with Nvidia.
Why was Jimmy Kimmel's late-night show suspended? Here's what we know
NEW YORK (AP) — ABC has pulled off the air, indefinitely — an unprecedented move that followed backlash from affiliated broadcasters and the head of the Federal Communications Commission over the comic's remarks about last week's killing of conservative activist .
Harvard Business School graduate arrested on charges he cheated fellow alums out of over $4 million
NEW YORK (AP) — A Harvard Business School graduate was arrested Thursday on fraud charges alleging he swindled fellow alumni of the prestigious school out of over $4 million in a Ponzi scheme, even assuring one investor they would soon “brag” about their “crazy gains” at the school's reunion.
Time to Say Goodbye to "Old" Dollar? Say Hello to "Trump's New Dollar" - Ad
If you have any money in U.S. dollars... learn how to prepare for "Trump's new dollar"... Because this could be the biggest change to our financial system in 54 years. President Trump even called it: "The greatest revolution in financial technology since the birth of the internet itself."
Trump Hints TikTok Deal May Finally Be Complete But GOP China Hawks Demand ByteDance Disinvestment And Full Algorithm Split
President Donald Trump hinted that a TikTok deal may be near, but GOP lawmakers insist any agreement must enforce ByteDance's full divestment and an algorithm split from China.
AstraZeneca's Fasenra Falls Short In Smoker's Lung Trial
AstraZeneca's Fasenra misses the primary COPD endpoint while Saphnelo's lupus trial shows significant improvements and consistent safety profiles.
Elon's $25 Trillion Confession - Ad
Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.
Oracle's Big AI Bet Faces Credit Risk, Rating Agency Warns
Oracle (NYSE: ORCL) stock rises as AI deals boost investor confidence. However, Moody's warns of risks in $300B AI contracts with OpenAI.
Microsoft resolves European Union probe into Teams
LONDON (AP) — European Union regulators have accepted Microsoft's to Teams, resolving a long-running antitrust investigation that targeted the company's messaging and videoconferencing app.
How the Multiplier Effect is Working on This $3 Crypto - Ad
It's called the multiplier effect in crypto. In short, because of a lack of supply, small inflows of cash can create major moves in the overall value of the crypto. And it's particularly strong in one $3 crypto. Crypto analysts are suggesting it could rise to as high as $100 by next year.
Bill, Melinda French Gates Teach Phoebe The Power Of People, Not Money, As Her AI Fashion-Tech Startup Secures $8 Million From Top Investors
Bill and Melinda Gates' daughter Phoebe builds successful fashion-tech company with focus on teamwork, advice from parents, and $8M funding.
Cathie Wood's Ark Bets Big On Solana Treasury Play: Makes $162M Investment In Brera Holdings As Stock Explodes 225%
On Thursday, Cathie Wood-led Ark Invest executed significant trades, notably selling shares of Tempus AI Inc (NASDAQ:TEM) and buying shares of Brera Holdings PLC (NASDAQ:BREA),
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.
Apple's iPhone 17 Series Takes Off, Meta's New Smart Glasses And Major Partnerships In AI Space: This Week In AI
This weekend's tech roundup featured Apple's strong iPhone 17 launch in China and India, Meta's new smart glasses, major AI partnerships like Intel-Nvidia and PayPal-Google, and Jim Cramer questioning Huawei's chip breakthrough.
Elizabeth Warren Says Measles Can Hit Record Highs, Slams RFK Jr.'s CDC Panel For Delaying Vaccine: 'How Does That Keep Our Kids Safe?'
Sen. Elizabeth Warren (D-Mass.) on Thursday criticized the Centers for Disease Control and Prevention's vaccine advisory panel following its controversial vote to delay the combined measles, mumps, rubella, and varicella or MMRV vaccine for children under 4 years old.
Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad
A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.
Big Tech's energy-hungry data centers could be bumped off grids during power emergencies
HARRISBURG, Pa. (AP) — With the explosive growth of Big Tech's data centers threatening to overload U.S. electricity grids, policymakers are taking a hard look at a tough-love solution: bumping the energy-hungry data centers off grids during power emergencies.
Labor Dispute Eases As UAW, GE Aerospace Agree On Tentative Pact
UAW members at GE Aerospace plants in Ohio and Kentucky reached a tentative deal, with a ratification vote set for Sept. 19.
Why This Crypto Skeptic Had a Change of Heart - Ad
He used to make fun of crypto. Now... he says one $3 crypto could rise to $92 by next year.
Trump Admin's Intel Stake Could Create 'Unintended Inefficiencies' In Global Chip Industry, Warns Fitch
The U.S. government's recent investment in Intel Corp. (NASDAQ: INTC) could lead to unintended inefficiencies in the global semiconductor industry, according to a report by Fitch Ratings.
Trump's Immigration Policies Could 'Shrink' GDP Growth As US Population Projected To Decline, Warns CBO
The U.S. population growth is expected to decline at a faster rate than previously projected due to President Donald Trump's immigration policies, according to the Congressional Budget Office (CBO).
New Biotech Offering Targets $426B Rare Disease Market - Ad
The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.
Trump Warns Russia As Fighter Jets Breach NATO Airspace: 'I Don't Love It…Could Be Big Trouble'
U.S. President Donald Trump warned that Russia's fighter jet incursion into Estonia's airspace "could be big trouble," as NATO scrambled jets, Estonia requested Article 4 consultations, and Trump tied his Russia sanctions strategy to unified NATO action and tariffs on China.
Warner Bros, Oracle, And Micron Technology Are Among The Top 10 Large-Cap Gainers Last Week (Sep. 8 - Sep. 12): Are The Others In Your Portfolio?
Deal buzz, analyst upgrades, and AI momentum drove top weekly gainers—led by Warner Bros., Oracle, and Micron—across large-cap tech and media.
Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad
This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.
Hillary Clinton Says Trump Administration Is 'Going Great' For The President, Dogecoin Rallies 20%, Silver Token Tops Bitcoin — This Week In Crypto
The past week has been a rollercoaster ride in the world of finance and politics. From silver-backed cryptocurrencies outperforming Bitcoin (CRYPTO: BTC) to Hillary Clinton’s accusations of crypto corruption against the Trump administration, there’s been no shortage of headlines.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.